Merger with INC Research inVentiv Health merged with INC Research Holdings, creating a major player in the contract-research industry. The combined entity provides biopharmaceutical solutions on a global scale, offering potential partnership opportunities for companies seeking comprehensive clinical and commercial support.

Public Offering With inVentiv Health going public, there is increased visibility and access to capital for further expansion and innovation. This development signals growth and potential collaborations with investors looking to engage with a prominent player in the pharmaceutical manufacturing space.

Strategic Acquisition by INC Research The acquisition of inVentiv Health by INC Research for $4.6 billion showcases a strong vote of confidence in the company's capabilities. This strategic move positions inVentiv Health as a key player for synergistic partnerships and collaborations aimed at driving mutual growth and success.

Industry Leadership Position InVentiv Health's stature as one of the world's largest contract-research companies places them in a prime position to attract new business opportunities. Their extensive expertise, global reach, and integrated solutions offer potential clients a reliable partner for navigating the complexities of the biopharmaceutical industry.

Experienced Leadership Team With a proven track record of successful mergers, acquisitions, and strategic hires, inVentiv Health boasts an experienced leadership team that can drive sales growth through industry knowledge, relationships, and innovative business strategies. Leveraging this expertise can open doors to new sales channels and strategic alliances.